Technology
Health
Medical

Tandem Diabetes Care

$71.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.27 (-0.38%) Today
-$0.24 (-0.33%) After Hours

Why Robinhood?

You can buy or sell TNDM and other stocks, options, ETFs, and crypto commission-free!

About

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. Read More The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.

Employees
653
Headquarters
San Diego, California
Founded
2006
Market Cap
4.14B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
2.49M
High Today
$73.60
Low Today
$71.00
Open Price
$71.66
Volume
529.29K
52 Week High
$74.75
52 Week Low
$3.65

Collections

Technology
Health
Medical
2013 IPO
US
North America

News

Yahoo FinanceMar 14

Tandem Diabetes (TNDM) Hits a 52-Week High on Solid Prospects

Share price of Tandem Diabetes Care, Inc. TNDM scaled a new 52-week high of $74.37 on Mar 13, closing nominally lower at $71.42. Over the past six months, the company has gained 39.6%. The stock has a market cap of $4.12 billion. Further, Tandem’s estimate revision trend for the current quarter is favorable. In the past 30 days, two estimates have moved up while none shifted down. Consequently, estimates were up from a loss of 35 cents per share to a loss of 28 cents. The company’s five-year histor...

1,008
Simply Wall StMar 12

Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) A Financially Strong Company?

Stocks with market capitalization between $2B and $10B, such as Tandem Diabetes Care, Inc. (NASDAQ:TNDM) with a size of US$3.8b, do not attract as much attention from the investing community as do the small-caps and large-caps. While they are less talked about as an investment category, mid-cap risk-adjusted returns have generally been better than more commonly focused stocks that fall into the small- or large-cap categories. Today we will look at TNDM’s financial liquidity and debt levels, which are strong...

1,228
Yahoo FinanceMar 11

Tandem Diabetes Signs as an Insulin Pump Vendor in Canada

In line with Tandem Diabetes Care, Inc.'s TNDM focus on strengthening its global presence, the company recently announced thatit has been registered as an approved vendor of insulin pumps and supplies under the Assistive Devices Program (ADP) in Ontario, Canada. This development came close on the heels of the company receiving a Heath Canada Medical Device License for its t:slim X2 Insulin Pump. This t:slim X2 Insulin Pump features Dexcom G5 Mobile continuous glucose monitoring (CGM) integration. This in t...

74

Earnings

-$3.83
-$2.55
-$1.26
$0.02
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Apr 25, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.